Utility of Lupus Anticoagulant Assays (APTT-LA, KCT, DPT and DRVVT) in Detection of Antiphospholipid Syndrome (APS) in High Risk Pregnancy Cases

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
Ankur AhujaDinesh Chandra

Abstract

Routine investigation for recurrent pregnancy loss includes measurement of antiphospholipid antibodies. The lupus anticoagulant has long been associated with increased risks for thrombosis and adverse obstetric outcomes. But there are some disadvantages with lupus anticoagulant (LAC) tests which includes varied sensitivity of different clot based assays. ISTH recommends only 2 assays (preferably DRVVT and APTT-LA) for the identification of lupus anticoagulant but there are some studies which don't support this contention. Our study analyzed 526 samples from high risk pregnancy cases for APLA by all four LAC tests from tertiary centre of northern India. Among all the cases studies 65 cases were positive for lupus anticoagulant 25 of this became negative after 12 weeks. Among the 40 repeated positive assays, dRVVT could able to diagnose 36 cases followed by APTT-LA which could able to diagnose 28 cases, while KCT could able to diagnose 23 cases and dPT could able to diagnose only 14 cases. There were 12 cases in whom all lupus assays were positive. Our study thus concluded that DRVVT was the most sensitive followed by APPT-LA, KCT, dPT. The combination of dRVVT with APTT-LA or KCT appeared to be superior to other combinations. No...Continue Reading

References

Sep 1, 1978·British Journal of Haematology·T ExnerH Kronenberg
Oct 1, 1985·American Journal of Obstetrics and Gynecology·W F Lubbe, G C Liggins
Nov 21, 1985·The New England Journal of Medicine·D W BranchE Hershgold
Feb 1, 1980·Annals of Internal Medicine·J R MuehS I Rapaport
Nov 29, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·L A Barbour, UNKNOWN ACOG Committee on Practice Bulletins--Obstetrics
Dec 23, 2004·Journal of Thrombosis and Haemostasis : JTH·I JenningsUNKNOWN UK National External Quality Assessment Scheme for Blood Coagulation
Apr 28, 2007·Journal of Thrombosis and Haemostasis : JTH·V PengoUNKNOWN Participating Centres of Italian Federation of Thrombosis Centres (FCSA)
May 26, 2009·Seminars in Perinatology·Lelia Duley
Jul 25, 2009·Journal of Thrombosis and Haemostasis : JTH·V PengoUNKNOWN Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the Interna
Jan 19, 2011·Blood Reviews·Rolf T Urbanus, Philip G de Groot
Jun 29, 2011·Journal of Thrombosis and Haemostasis : JTH·J SwadzbaJ Musial
Feb 9, 2012·British Journal of Haematology·David KeelingUNKNOWN British Committee for Standards in Haematology
Nov 20, 2012·Acta Obstetricia Et Gynecologica Scandinavica·Linda Björk HelgadóttirEva-Marie Jacobsen
Jan 4, 2015·Autoimmunity Reviews·Jaume Alijotas-ReigUNKNOWN (EUROAPS Study Group Collaborators)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.